358 related articles for article (PubMed ID: 29846803)
1. Quantitative characterisation of clinically significant intra-prostatic cancer by prostate-specific membrane antigen (PSMA) expression and cell density on PSMA-11.
Domachevsky L; Goldberg N; Bernstine H; Nidam M; Groshar D
Eur Radiol; 2018 Dec; 28(12):5275-5283. PubMed ID: 29846803
[TBL] [Abstract][Full Text] [Related]
2. Establishment and prospective validation of an SUV
Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
[No Abstract] [Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study.
Domachevsky L; Bernstine H; Goldberg N; Nidam M; Catalano OA; Groshar D
Eur Radiol; 2020 Jan; 30(1):328-336. PubMed ID: 31332559
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer.
Bates A; Miles K
Eur Radiol; 2017 Dec; 27(12):5290-5298. PubMed ID: 28608163
[TBL] [Abstract][Full Text] [Related]
6. Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.
Kershah S; Partovi S; Traughber BJ; Muzic RF; Schluchter MD; O'Donnell JK; Faulhaber P
Mol Imaging Biol; 2013 Dec; 15(6):776-85. PubMed ID: 23632951
[TBL] [Abstract][Full Text] [Related]
7.
Koerber SA; Utzinger MT; Kratochwil C; Kesch C; Haefner MF; Katayama S; Mier W; Iagaru AH; Herfarth K; Haberkorn U; Debus J; Giesel FL
J Nucl Med; 2017 Dec; 58(12):1943-1948. PubMed ID: 28619734
[No Abstract] [Full Text] [Related]
8. Early
Domachevsky L; Bernstine H; Goldberg N; Nidam M; Stern D; Sosna J; Groshar D
Clin Radiol; 2017 Nov; 72(11):944-950. PubMed ID: 28716214
[TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
Rowe SP; Gage KL; Faraj SF; Macura KJ; Cornish TC; Gonzalez-Roibon N; Guner G; Munari E; Partin AW; Pavlovich CP; Han M; Carter HB; Bivalacqua TJ; Blackford A; Holt D; Dannals RF; Netto GJ; Lodge MA; Mease RC; Pomper MG; Cho SY
J Nucl Med; 2015 Jul; 56(7):1003-1010. PubMed ID: 26069305
[TBL] [Abstract][Full Text] [Related]
10. Combined Utility of
Kalapara AA; Ballok ZE; Ramdave S; O'Sullivan R; Ryan A; Konety B; Grummet JP; Frydenberg M
Eur Urol Oncol; 2022 Jun; 5(3):314-320. PubMed ID: 33741337
[TBL] [Abstract][Full Text] [Related]
11. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Validation of PSMA Expression Measured by
Woythal N; Arsenic R; Kempkensteffen C; Miller K; Janssen JC; Huang K; Makowski MR; Brenner W; Prasad V
J Nucl Med; 2018 Feb; 59(2):238-243. PubMed ID: 28775203
[No Abstract] [Full Text] [Related]
13. Is there a nonnegligible effect of maximum standardized uptake value in the staging and management of prostate cancer with 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography imaging? A single-center experience.
Ekmekcioglu O; Yavuzsan AH; Arican P; Kirecci SL
J Cancer Res Ther; 2021; 17(6):1351-1357. PubMed ID: 34916365
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-PSMA-11 PET/CT combining ADC value of MRI in the diagnosis of naive prostate cancer: Perspective of radiologist.
Wang L; Yu F; Yang L; Zang S; Xue H; Yin X; Guo H; Sun H; Wang F
Medicine (Baltimore); 2020 Sep; 99(36):e20755. PubMed ID: 32898989
[TBL] [Abstract][Full Text] [Related]
15. Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
Surov A; Meyer HJ; Schob S; Höhn AK; Bremicker K; Exner M; Stumpp P; Purz S
Oncotarget; 2017 Apr; 8(17):28285-28296. PubMed ID: 28423698
[TBL] [Abstract][Full Text] [Related]
16.
Svirydenka H; Muehlematter UJ; Nagel HW; Delso G; Ferraro DA; Kudura K; Burger IA; Ter Voert EEGW
Eur Radiol; 2020 Jun; 30(6):3188-3197. PubMed ID: 32060711
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer evaluation using PET quantification in
Domachevsky L; Goldberg N; Gorenberg M; Bernstine H; Groshar D; Catalano OA
Quant Imaging Med Surg; 2020 Jan; 10(1):40-47. PubMed ID: 31956527
[TBL] [Abstract][Full Text] [Related]
18. The role of (
Yilmaz U; Komek H; Can C; Altindag S
Ann Nucl Med; 2019 Aug; 33(8):545-553. PubMed ID: 31069696
[TBL] [Abstract][Full Text] [Related]
19.
Xue AL; Kalapara AA; Ballok ZE; Levy SM; Sivaratnam D; Ryan A; Ramdave S; O'Sullivan R; Moon D; Grummet JP; Frydenberg M
J Urol; 2022 Feb; 207(2):341-349. PubMed ID: 34546815
[TBL] [Abstract][Full Text] [Related]
20. The role of PSMA PET/CT in predicting downgrading in patients with Gleason score 4+4 prostate cancer in prostate biopsy.
Aykanat IC; Kordan Y; Seymen H; Koseoglu E; Ozkan A; Esen B; Tarim K; Kulac I; Falay O; Gurses B; Baydar DE; Canda AE; Balbay MD; Demirkol MO; Esen T
World J Urol; 2024 May; 42(1):341. PubMed ID: 38771329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
